Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3YKX2
|
|||
| Drug Name |
US-APR2020
|
|||
| Drug Type |
Live biotherapeutic
|
|||
| Indication | Chronic kidney disease [ICD-11: GB61; ICD-10: N18, N18.9] | Phase 2/3 | [1] | |
| Company |
Kibow Biotech Newtown Square, PA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05407389) An Open-Label Rollover Extension Phase 2 Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.